Homepage

Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries

Screening Compounds Building blocks

Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls

Company News & Media Contact us For suppliers Trends in discovery compounds

Homepage > Company > Media > Pharma News > 2020

Pharma News, 2020

Gilead Sciences to buy 49.9% stake in Tizona Therapeutics for $300m

Gilead Sciences to buy 49.9% stake in Tizona Therapeutics for $300m

Gilead Sciences has agreed to invest up to $300m to acquire a 49.

Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat

Unichem Laboratories gets USFDA nod for drug to treat irregular heartbeat

Drug firm Unichem Laboratories NSE 1.

Jazz’s Xywav, a low-sodium alternative to blockbuster Xyrem, snags FDA nod in narcolepsy

Jazz’s Xywav, a low-sodium alternative to blockbuster Xyrem, snags FDA nod in narcolepsy

Jazz Pharmaceuticals’ Xyrem has become the standard of care for two symptoms of narcolepsy since its FDA approval in 2002.

U.S. to pay Pfizer, BioNTech $1.95 billion for 100 million COVID-19 vaccine doses

U.S. to pay Pfizer, BioNTech $1.95 billion for 100 million COVID-19 vaccine doses

(Reuters) - The U.

SK Bioscience to contract manufacture AstraZeneca’s COVID-19 vaccine in Korea

SK Bioscience to contract manufacture AstraZeneca’s COVID-19 vaccine in Korea

SK Bioscience, the vaccines business unit of SK Group, signed a trilateral memorandum of understanding with Korea’s Health Ministry and global biopharma AstraZeneca, to contract manufacture the latt...

Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients With Mild to Moderate COVID-19

Glenmark Announces Top-Line Results From Phase 3 Clinical Trial of Favipiravir in Patients With Mild to Moderate COVID-19

MUMBAI, India, July 22, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd.

Oxytocin, the ‘love hormone’, could be used to treat Alzheimer’s disease

Oxytocin, the ‘love hormone’, could be used to treat Alzheimer’s disease

Oxytocin is known to facilitate certain cellular chemical activities that are important in strengthening neuronal signalling potential and formation of memories, such as the influx of calcium ions.

Avanti Polar Lipids Agrees to be Acquired by Croda

Avanti Polar Lipids Agrees to be Acquired by Croda

ALABASTER, Alabama.

$Grifols to acquire Green Cross plasma fractionation facility in Montreal and a plasma collection organization in the U.S. for US$460 million$

Grifols to acquire Green Cross plasma fractionation facility in Montreal and a plasma collection organization in the U.S. for US$460 million

Barcelona, Spain, July 20, 2020.

Sanofi eyes acquisitions in US, including Principia Biopharma: report

Sanofi eyes acquisitions in US, including Principia Biopharma: report

According to sources, Sanofi is looking at potential acquisitions in the US, including Principia Biopharma, as it aims to boost its pipeline in areas such as multiple sclerosis and immune disorders, B...

Bayer: Vericiguat is primarily tested by the FDA in the USA

Bayer: Vericiguat is primarily tested by the FDA in the USA

Bayer’s heart failure drug Vericiguat has received the status of “Priority Review” from the US agency FDA and is therefore a priority.

Indian police arrest 14 for black market remdesivir as COVID-19 cases jump

Indian police arrest 14 for black market remdesivir as COVID-19 cases jump

MUMBAI (Reuters) - Indian police have arrested 14 people on suspicion of selling locally made doses of Gilead Sciences Inc’s remdesivir at five times the maximum retail price as a surge of n...

31 32 33 343536 37 38 39